RANDOMIZED STUDY OF PEMETREXED PLUS CARBOPLATIN FOLLOWED BY PEMETREXED VERSUS PACLITAXEL PLUS CARBOPLATIN FOLLOWED BY PEMETREXED IN NON-SQUAMOUS NSCLC (LOGIK0904)

被引：0
|
作者：
Moriwaki, Atsushi [1 ,10 ]
Inoue, Koji [2 ,10 ]
Takeshita, Masafumi [2 ,10 ]
Harada, Taishi [3 ,10 ]
Tashiro, Naoki [4 ,10 ]
Seto, Takashi [5 ,10 ]
Imanaga, Tomotoshi [1 ,10 ]
Fujimoto, Noriko [6 ,10 ]
Nakagaki, Noriaki [7 ,10 ]
Kawasaki, Masayuki [8 ,10 ]
Kishimoto, Junji [9 ,10 ]
Takayama, Koichi [3 ,10 ]
Ichinose, Yukito [5 ,10 ]
机构：
[1] Steel Mem Yawata Hosp, Dept Resp Dis, Kitakyushu, Fukuoka, Japan
[2] Kitakyushu Municipal Med Ctr, Dept Resp Med, Kitakyushu, Fukuoka, Japan
[3] Kyushu Univ, Res Inst Dis Chest, Grad Sch Med Sci, Fukuoka 812, Japan
[4] Fukuoka Univ, Sch Med, Dept Resp Med, Fukuoka 81401, Japan
[5] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan
[6] St Marys Hosp, Dept Resp Dis, Fukuoka, Japan
[7] Natl Hosp Org Fukuoka Higashi Med Ctr, Dept Resp Dis, Fukuoka, Japan
[8] Natl Hosp Org Omuta Hosp, Dept Resp Med, Fukuoka, Japan
[9] Kyushu Univ Hosp, Ctr Clin & Translat Res, Fukuoka 812, Japan
[10] Lung Oncol Grp Kyushu, Fukuoka, Japan
来源：
RESPIROLOGY | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [21] SAFETY AND RESOURCE USE IN PRONOUNCE: A RANDOMIZED, PHASE 3, OPEN-LABEL STUDY OF PEMETREXED PLUS CARBOPLATIN WITH MAINTENANCE PEMETREXED (PEMC) AND PACLITAXEL PLUS CARBOPLATIN PLUS BEVACIZUMAB WITH MAINTENANCE BEVACIZUMAB (PCB) IN PATIENTS WITH ADVANCED NON-SQUAMOUS (NS) NON-SMALL-CELL LUNG CANCER (NSCLC)
    Ross, Helen J.
    Spigel, David
    Weaver, Robert W.
    Govindan, Ramaswamy
    Holden, Viran
    Chowhan, Naveed M.
    Beck, Thaddeus
    Waterhouse, David
    Modiano, Manuel R.
    Rao, Vijay P.
    Winfree, Katherine B.
    Melemed, Symantha
    Liu, Jingyi
    Koustenis, Andrew G.
    Guba, Susan C.
    Ortuzar, Waldo I.
    Obasaju, Coleman
    Zinner, Ralph
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S578 - S578
  • [22] Treatment Rationale and Study Design for a Randomized Trial of Pemetrexed/Carboplatin Followed by Maintenance Pemetrexed Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients With Advanced Non-Small-Cell Lung Cancer of Nonsquamous Histology
    Zinner, Ralph G.
    Saxman, Scott B.
    Peng, Guangbin
    Monberg, Matthew J.
    Ortuzar, Waldo I.
    [J]. CLINICAL LUNG CANCER, 2010, 11 (05) : 352 - 357
  • [23] A Phase I/Ib Study of Binimetinib (MEK162), a MEK Inhibitor Plus Carboplatin/Pemetrexed in Non-Squamous NSCLC
    Graham, D.
    Chen, E.
    Pisters, K.
    Bradbury, P.
    Trinkaus, M.
    Chan, M.
    Arif, S.
    Zurawska, U.
    Rothenstein, J.
    Zawisza, D.
    Effendie, S.
    Sawczak, M.
    Leighl, N.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S481 - S482
  • [24] Anlotinib plus carboplatin/pemetrexed in treatment-naive advanced non-squamous NSCLC: An open-label, randomized, phase II study
    Guo, R.
    Gao, W.
    Li, J.
    Liu, Y.
    Liu, X.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S801 - S801
  • [25] Pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for advanced non-squamous non-small cell lung cancer (NSCLC)
    Patel, J. D.
    Hensing, T. A.
    Rademaker, F.
    Hart, E.
    Obasaju, C. K.
    Treat, J.
    Milton, D.
    Bonomi, P. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] Randomized phase III study comparing carboplatin plus pemetrexed followed by pemetrexed versus docetaxel in elderly patients with advanced non-squamous non-small-cell lung cancer (JCOG1210/WJOG7813L).
    Okamoto, Isamu
    Nokihara, Hiroshi
    Yoh, Kiyotaka
    Sugawara, Shunichi
    Horinouchi, Hidehito
    Azuma, Koichi
    Yoneshima, Yasuto
    Murakami, Haruyasu
    Daga, Haruko
    Hosomi, Yukio
    Atagi, Shinji
    Ozaki, Tomohiro
    Horiike, Atsushi
    Fujita, Yuka
    Okamoto, Hiroaki
    Ando, Masahiko
    Nomura, Shogo
    Yamamoto, Nobuyuki
    Ohe, Yuichiro
    Nakagawa, Kazuhiko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] Efficacy and safety of first-line pemetrexed plus carboplatin followed by single-agent pemetrexed maintenance in elderly Chinese patients with non-squamous non-small-cell lung cancer
    Zhao, Xinmin
    Yu, Hui
    Zhao, Jing
    Wu, Xianghua
    Sun, Si
    Luo, Zhiguo
    Wang, Huijie
    Qiao, Jie
    Chang, Jianhua
    Wang, Jialei
    [J]. ONCOTARGET, 2017, 8 (49) : 86384 - 86394
  • [29] Prospective Multicenter Study of Pemetrexed and Carboplatin Combination Followed by Maintenance Pemetrexed in Chemo-naive Patients With Non-squamous Non-small Cell Lung Cancer
    Hosomi, Y.
    Satouchi, M.
    Mori, K.
    Enatsu, S.
    Sekiguchi, R.
    Tominaga, K.
    Nakagawa, K.
    Tamura, T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S631 - S632
  • [30] A COST-EFFECTIVENESS ANA LYSIS OF CISPLATIN PLUS PEMETREXED DOUBLET INDUCTION TREATMENT FOLLOWED BY PEMETREXED MAINTENANCE COMPARED WITH BEVACIZUMAB PLUS CISPLATIN PLUS GEMCITABINE TRIPLET INDUCTION TREATMENT FOLLOWED BY BEVACIZUMAB MAINTENANCE FOR NON-SQUAMOUS NSCLC IN SWEDEN
    Bryden, P. A.
    Kumar, G.
    Winfree, K. B.
    Boye, M. E.
    Taipale, K.
    Thompson, R.
    Borgeke, H.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A410 - A410
12345